Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-017958
Filing Date
2016-01-22
Accepted
2016-01-22 19:35:08
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 - edgar.html 5  
1 FORM 5 - edgar.xml 5 3434
  Complete submission text file 0001179110-16-017958.txt   5001
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INVIVO THERAPEUTICS HOLDINGS CORP. ONE KENDALL SQUARE, STE B14402 CAMBRIDGE MA 02139
Business Address
MCALLISTER STEVEN F (Reporting) CIK: 0001595101 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37350 | Film No.: 161357269